Tasso

Tasso is a healthcare technology company that is transforming the traditional blood collection paradigm with a patient-centric approach. The company has developed innovative, virtually painless blood collection devices that enable simple, convenient sampling for users without the need for painful fingersticks or traditional venipuncture procedures.

Headquartered in Seattle, Washington, Tasso offers a portfolio of FDA-cleared blood lancet devices including Tasso+, Tasso Mini, and Tile-T20. These devices utilize a button-based mechanism with light adhesive that creates a vacuum to collect capillary blood samples with minimal discomfort. The company serves pharmaceutical companies, clinical research organizations, hospital systems, and healthcare providers seeking to improve patient experience in diagnostic testing.

Tasso's technology has been deployed across diverse applications including pharmaceutical clinical trials, Olympic athlete testing programs, and broad healthcare system implementations. The company holds regulatory clearances including FDA 510(k) Class II clearance, CE Marking for Europe, MHRA registration, and Health Canada licensing. Their mission centers on bringing diagnostic testing to the home to improve patient experience and enable people to make more informed healthcare decisions.